DEERFIELD MANAGEMENT COMPANY, L.P.
Position in NBIX — Neurocrine Biosciences Inc
CIK 1009258
NEW YORK, NY
Position in NBIX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$80,361,400
-$87,614,251 QoQ
Shares Held
610,000
-48.5% QoQ
Ownership
0.600%
of shares outstanding
% of Portfolio
1.56%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026DEERFIELD MANAGEMENT COMPANY, L.P. holds $870,646,189 across 5 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
20,206,170 | $320,873,979 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
457,000 | $247,616,310 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
15,096,403 | $150,964,030 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
752,999 | $83,537,709 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,648,895 | $67,654,161 |
All Filings in NBIX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $80,361,400 | 610,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $167,975,651 | 1,184,345 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $166,258,351 | 1,184,345 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $146,781,033 | 1,167,802 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $164,683,400 | 1,489,000 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $117,663,000 | 862,000 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $151,697,499 | 1,316,590 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $95,130,520 | 691,004 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $95,303,271 | 691,004 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $118,151,695 | 896,719 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $136,092,825 | 1,209,714 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $114,076,030 | 1,209,714 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $176,599,951 | 1,744,714 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $180,678,560 | 1,512,714 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $160,665,353 | 1,512,714 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $196,199,360 | 2,012,714 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $155,418,750 | 1,657,800 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $117,359,575 | 1,377,945 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $109,569,022 | 1,142,415 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $70,557,000 | 725,000 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $70,506,250 | 725,000 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||